Principia Biopharma Inc. (PRNB): Price and Financial Metrics


Principia Biopharma Inc. (PRNB)

Today's Latest Price: $30.25 USD

1.27 (-4.03%)

Updated Oct 18 6:55pm

Add PRNB to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PRNB Daily Price Range
PRNB 52-Week Price Range

PRNB Stock Price Chart More Charts


PRNB Price/Volume Stats

Current price $30.25
Prev. close $31.52
Day low $29.23
Day high $31.54
50-day MA $33.70
200-day MA $32.99
52-week high $42.34
52-week low $22.01
Volume 474,800
Avg. volume 134,585
Dividend yield N/A
Market Cap 730.66M

Principia Biopharma Inc. (PRNB) Company Bio


Principia Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on developing novel oral therapies for immunology and oncology in the United States. It is developing PRN1008, an inhibitor that is in Phase II clinical trial for the treatment of pemphigus, a chronic skin disease, as well as in Phase II clinical trial for the treatment of immune thrombocytopenic purpura; PRN2246, an inhibitor that is in Phase I clinical trial for the treatment of multiple sclerosis and other central nervous system diseases; PRN1371, a drug candidate, which is in Phase I clinical trial for the treatment of solid tumors; and oral small molecule inhibitors of the immunoproteasome. The company has collaboration agreements with Genzyme Corporation and AbbVie Biotechnology Limited. Principia Biopharma Inc. was founded in 2008 and is based in South San Francisco, California.





PRNB Latest News Stream


Event/Time News Detail
Loading, please wait...

PRNB Latest Social Stream


Loading social stream, please wait...

View Full PRNB Social Stream

PRNB Price Returns

1-mo -11.06%
3-mo -22.52%
6-mo 4.17%
1-year 27.58%
3-year N/A
5-year N/A
YTD 10.44%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.3698 seconds.